A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

By R. Mehran, E. Aymong, E. Nikolsky, Z. Lasić, I. Iakovou, M. Fahy, G. Mintz, A. Lansky, J. Moses, Gregg Stone and 2 more. Journal of the American College of Cardiology, 2004

2,459 citations recorded by the source corpus.

Subfields: Nephrology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/3d097346d951c8a801275af84a483c464b99b9de

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Stacul
2. A. Molen
3. P. Camici
4. R. Dalman
5. K. Thygesen
6. M. Simoons
7. K. Fox
8. P. Reimer

Citations in the corpus

• The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018, background): “Patients with renal disease (eGFR # 45 mL/min/1.73 m2), diabetes, congestive heart failure, ejection fraction 40%, hypertension, anemia, advanced age, proteinuria, and gout are at increased risk for CIN.130 Gadolinium is not a safe alternative to iodinated contrast agents, given the risk for nephro”
• Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines (2011, background): “A number of percutaneous coronary intervention (PCI) studies have shown that congestive heart failure (New York Heart Association [NYHA] grade 3–4) is associated with a higher incidence of CIN [20, 23, 24, 31].”
• [Guidelines on the management of stable angina pectoris: executive summary]. (2006, background): “75 years is an important predictor of contrast-induced nephropathy.(301) Medical treatment is more complex in elderly patients.”